semaglutide and sjogren's as a potential therapeutic adjunct for reducing flare-ups in Sjögren's syndrome: A case report Potential Sjögren's drugs may herald

Parallel efforts are exploring new indications, including neurodegenerative and substance use disorders, metabolic liver disease, arthritis, type 1 diabetes and inflammatory bowel disease

Melanotan II is used as a tanning agent because it causes the skin to darken more quickly and easily upon sun exposure

This article explains Retatrutide weight loss results trial data and FDA status, including how it may work, what trial results showed, possible side effects, and why medical guidance matters before starting any weight-loss plan

For researchers and interested readers, monitoring registered clinical trial databases such as ClinicalTrials.gov and peer-reviewed preclinical journals remains the most reliable way to track meaningful new developments